Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Costs and effectiveness of genomic testing in the management of colorectal cancer.

Oncology (Williston Park, N.Y.) - 1 Mar 2015

Goldstein Daniel A, Shaib Walid L, Flowers Christopher R

Abstract excerpt

Numerous genomic tests are available for use in colorectal cancer, with a widely variable evidence base for their effectiveness and cost-effectiveness. In this review, we highlight many of these tests, with a focus on their proposed role, the evidence base to support that role, and the associated costs and risks. The tests with the strongest evidence base are KRAS genetic testing in the metastatic setting and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Care Costs

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Risk Assessment

Source

Identifiers

PMID: 25783977

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Costs and effectiveness of genomic testing in the management of colorectal cancer.PMID 25783977Read ↗

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.Semantic proximity Read ↗

[II. Clinical Guidelines of Molecular Testing for Colorectal Cancer].Semantic proximity Read ↗

The Evolving Role of Genomics in Colorectal Cancer.Semantic proximity Read ↗

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.Semantic proximity Read ↗

Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerationsSemantic proximity Read ↗

New Guideline on Managing Colorectal Cancer.Semantic proximity Read ↗

Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and polygenic risk scores to inform colorectal cancer screeningSemantic proximity Read ↗

Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation Profile.Semantic proximity Read ↗

Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.Semantic proximity Read ↗

Clinical utility of comprehensive genomic profiling test for colorectal cancer: A single institution prospective observational studySemantic proximity Read ↗

Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testingSemantic proximity Read ↗

Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.